Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a ...

Ionis Pharmaceuticals CEO Brett Monia stated: "Today's FDA approval of TRYNGOLZA heralds the arrival of the first-ever FCS ...

US-based biotechnology company Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma ...

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, ...

A RECENT multicentre, randomised clinical trial has found that discontinuing first-line disease-modifying therapy (DMT) in ...

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpoints; ...

The study was carried out in 1,232 participants in the PREDIMED project, a major scientific epidemiological study in ...

Light and moderate consumption of wine is associated with a lower risk of cardiovascular complications, according to a multicenter study. The study is based on the analysis of a biomarker of wine ...

Immunocore Holdings has dosed the first subject in a multicentre Phase I/II trial of IMC-R117C, a PIWIL1-targeted ...

The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...

Light and moderate consumption of wine is associated with a lower risk of cardiovascular complications, according to a ...